Do you want to read an article? Please log in or register.
What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question
Multiple Sclerosis
Related content
RECOMMENDED
Multiple Sclerosis
Advances in oral immunomodulating therapies in relapsing multiple sclerosis
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Lancet Neurol.
Derfuss T, Mehling M, Papadopoulou A, Bar-Or A, Cohen JA, Kappos L
doi: 10.1016/S1474-4422(19)30391-6.
RECOMMENDED
Multiple Sclerosis
Paediatric multiple sclerosis: a new era in diagnosis and treatment
Dev Med Child Neurol.
Duignan S, Brownlee W, Wassmer E, Hemingway C, Lim M, Ciccarelli O, Hacohen Y
doi: 10.1111/dmcn.
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
Multiple Sclerosis
A new era of multiple sclerosis rehabilitation: lessons from stroke
Lancet Neurol.
Ploughman M
doi: 10.1016/
SPECIAL REPORT
Multiple Sclerosis
Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis
RECOMMENDED
Multiple Sclerosis
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis
Lancet Neurol.
Ontaneda D, Tallantyre E, Kalincik T, Planchon SM, Evangelou N
doi: 10.1016/S1474-4422(19)30151-6.
Multiple Sclerosis
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Brain.
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP
doi: 10.1093/brain/aww258.
RECOMMENDED
Multiple Sclerosis
Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study
Ther Adv Neurol Disord.
Kallmann BA, Tiel-Wilck K, Kullmann JS, Engelmann U, Chan A
doi: 10.1177/
COMMENTED
Multiple Sclerosis
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland
Mult Scler J Exp Transl Clin.
Kaufmann M, Kuhle J, Puhan MA, Kamm CP, Chan A, Salmen A, Kesselring J, Calabrese P, Gobbi C, Pot C, Steinemann N, Rodgers S, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR)
doi: 10.1177/2055217318814562.